Abstract:Tumor necrosis factor-α induced protein 8 like-2 (TNFAIP8L2, TIPE2), a lately discovered negative regulator of innate immunity and cellular immunity, shares considerable sequence homology with members of the tumor necrosis factor-α induced protein 8 (TNFAIP8) family. It is preferentially expressed in lymphoid-derived and marrow-derived cells. However, it is unclear whether TIPE2 is expressed in the regulatory T cells (Tregs) to contribute to its negative regulatory property in immune response. The present study was designed to examine whether naturally occurring CD4(+)CD25(+) Tregs isolated from murine spleens expressed TIPE2 by the use of Western blot and reverse transcription-polymerase chain reaction (RT-PCR). Based on the expression of cell surface molecules, including cytotoxic T-lymphocyte-associated antigen (CTLA)-4 and forkhead/winged helix transcription factor p3 (Foxp3) on CD4(+)CD25(+) Tregs, and cytokines including interleukin (IL)-10 as well as transforming growth factor (TGF)-β were analyzed to investigate the functional role of TIPE2 in controlling suppressive activity of CD4(+)CD25(+) Tregs. Meanwhile, IL-2, the ratio of interferon (IFN)-γ/IL-4 in CD4(+)CD25(+)Treg/CD4(+)CD25(-) T cell coculture supernatant and nuclear factor of activated T cells (NF-AT) activation in T lymphocytes were determined to examine the effects of TIPE2 on the T-cell proliferation and differentiation induced by CD4(+)CD25(+) Tregs. It was found that TIPE2 was a cytoplasmic protein expressed in CD4(+)CD25(+) Tregs, and cell surface molecules as well as cytokines (IL-10, TGF-β) expressions were significantly down-regulated when TIPE2 gene silenced by siRNA. On the other hand, CD4(+)CD25(+) Tregs treated with TIPE2 knock-down promoted T-cell proliferation as well as differentiation, and markedly upregulated IL-2 expression and intranuclear NF-AT activation. The results suggested that TIPE2 appeared to be a critical immunoregulatory molecule involved in immunosuppressive function of CD4(+)CD25(+) Tregs.

Tissue-specific expression of TIPE2 provides insights into its function.

The Unique Expression Profile of Human TIPE2 Suggests New Functions Beyond Its Role in Immune Regulation.

The Expression of Tipe1 in Murine Tissues and Human Cell Lines

TIPE2: A Candidate for Targeting Antitumor Immunotherapy.

Identical expression profiling of human and murine TIPE3 protein reveals links to its functions.

Expression of Tumor Necrosis Factor-Α Induced Protein 8 Like-2 Contributes to the Immunosuppressive Property of CD4+CD25+ Regulatory T Cells in Mice

Research progress of TIPE2 in immune-related diseases

Understanding the roles of negative immune regulator TIPE2 in different diseases and tumourigenesis.

Update in Immune Regulatory Pathway of Tumor Necrosis Factor-Α-induced Protein 8-Like 2

TIPE2 Negatively Regulates Mycoplasma Pneumonia-Triggered Immune Response Via MAPK Signaling Pathway

Tumor Necrosis Factor--Induced Protein 8-Like 2 Negatively Regulates Innate Immunity Against RNA Virus by Targeting RIG-I in Macrophages

Effect of Tumor Necrosis Factor-Α Induced Protein 8 Like-2 on Immune Function of Dendritic Cells in Mice Following Acute Insults

Regulatory Roles of Tumor Necrosis Factor-α-Induced Protein 8 Like-Protein 2 in Inflammation, Immunity and Cancers: A Review

The TIPE (TNFAIP8) family in inflammation, immunity, and cancer

Epithelial TIPE1 Protein Guards against Colitis by Inhibiting TNF-α-Mediated Inflammation

Exacerbated Experimental Colitis in TNFAIP8-deficient Mice.

TIPE2 Negatively Regulates Inflammation by Switching Arginine Metabolism from Nitric Oxide Synthase to Arginase.

Tumor Necrosis Factor (Tnf)-Α-induced Protein 8-Like-2 (TIPE2) Inhibits Proliferation and Tumorigenesis in Breast Cancer Cells.

In Silico and in Vivo Analysis of TIPE1 Expression in Diffuse Large B Cell Lymphoma

Expression of TIPE family members in human colorectal cancer

Clinical Significance of TIPE2 Protein Upregulation in Non-Hodgkin's Lymphoma.